RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
REGENTIS BIOMATERIALS LTD.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$1.48−0.01 (-0.67%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Regentis Biomaterials's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 1,428,570 | 9.90% | 13G (passive) | Jun 30, 2026 |
| Dr. Ehud Geller | 1,332,867 | 23.20% | 13G (passive) | Dec 31, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ehud Geller | Chief Executive Officer, Director | – | – | Jul 13, 2026 |
| Galit Reske | Chief Medical Officer | – | – | Mar 30, 2026 |
| Arie Gordashnikov | Chief Accounting Officer | – | – | Mar 18, 2026 |
| Ori Gon | Chief Financial Officer | – | – | Mar 18, 2026 |
| Susan PHD Alpert MD | Director | – | – | Jul 13, 2026 |
| Pini Ben-Elazar | Director | 128,666 | 2.48% | Jul 13, 2026 |
| Efraim Cohen-Arazi | Director | – | – | Jul 13, 2026 |
| Jeff Dykan | Director | 270,473 | 5.22% | Jul 13, 2026 |
| Keith Valentine | Director | – | – | Jul 13, 2026 |